Literature DB >> 30052492

Quis Custodiet Ipsos Custodes? Regulation of Cell-Mediated Immune Responses Following Viral Lung Infections.

Meredith C Rogers1,2, John V Williams1,3.   

Abstract

Viral lung infections are leading causes of morbidity and mortality. Effective immune responses to these infections require precise immune regulation to preserve lung function after viral clearance. One component of airway pathophysiology and lung injury associated with acute respiratory virus infection is effector T cells, yet these are the primary cells required for viral clearance. Accordingly, multiple immune mechanisms exist to regulate effector T cells, limiting immunopathology while permitting clearance of infection. Much has been learned in recent years about regulation of T cell function during chronic infection and cancer, and it is now clear that many of these mechanisms also control inflammation in acute lung infection. In this review, we focus on regulatory T cells, inhibitory receptors, and other cells and molecules that regulate cell-mediated immunity in the context of acute respiratory virus infection.

Entities:  

Keywords:  PD-1; RSV; Treg; influenza; inhibitory receptor; metapneumovirus; regulatory T cell

Mesh:

Year:  2018        PMID: 30052492     DOI: 10.1146/annurev-virology-092917-043515

Source DB:  PubMed          Journal:  Annu Rev Virol        ISSN: 2327-056X            Impact factor:   10.431


  7 in total

Review 1.  The Immune Responses against Coronavirus Infections: Friend or Foe?

Authors:  Arefe Vafaeinezhad; Mohammad Reza Atashzar; Rasoul Baharlou
Journal:  Int Arch Allergy Immunol       Date:  2021-05-05       Impact factor: 2.749

2.  The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia.

Authors:  Hui Li; Kailan Chen; Maochang Liu; Hua Xu; Qiong Xu
Journal:  J Infect       Date:  2020-04-20       Impact factor: 6.072

Review 3.  Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment In COVID-19.

Authors:  Isabella Orienti; Giovanna Angela Gentilomi; Giovanna Farruggia
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

Review 4.  Cell-Mediated Responses to Human Metapneumovirus Infection.

Authors:  Marlies Ballegeer; Xavier Saelens
Journal:  Viruses       Date:  2020-05-14       Impact factor: 5.048

Review 5.  A motley of possible therapies of the COVID-19: reminiscing the origin of the pandemic.

Authors:  Ishnoor Kaur; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Vetriselvan Subramanian; Shivkanya Fuloria; Neeraj Kumar Fuloria; Mahendran Sekar; Hamed Ghaleb Dailah; Amal M Alsubayiel; Saurabh Bhatia; Ahmed Al-Harrasi; Lotfi Aleya; Simona Bungau
Journal:  Environ Sci Pollut Res Int       Date:  2022-08-06       Impact factor: 5.190

Review 6.  A comprehensive review on modulation of SIRT1 signaling pathways in the immune system of COVID-19 patients by phytotherapeutic melatonin and epigallocatechin-3-gallate.

Authors:  Vineeta Chattree; Kamana Singh; Kanishk Singh; Aayush Goel; Amritaparna Maity; Asif Lone
Journal:  J Food Biochem       Date:  2022-06-03       Impact factor: 3.654

Review 7.  Clinical Trials for Use of Melatonin to Fight against COVID-19 Are Urgently Needed.

Authors:  Konrad Kleszczyński; Andrzej T Slominski; Kerstin Steinbrink; Russel J Reiter
Journal:  Nutrients       Date:  2020-08-24       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.